Endurant Capital Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,906
Closed -$848K 18
2023
Q4
$848K Sell
3,906
-4,972
-56% -$853K 4.86% 8
2023
Q3
$1.42M Buy
+8,878
New +$1.99M 1.27% 26
2022
Q1
Sell
-6,394
Closed -$1.7M 80
2021
Q4
$1.7M Buy
+6,394
New +$1.85M 0.41% 45
2020
Q3
Sell
-2,465
Closed -$479K 70
2020
Q2
$479K Buy
+2,465
New +$471K 0.03% 52
2019
Q1
Sell
-40,727
Closed -$3.23M 83
2018
Q4
$3.23M Buy
+40,727
New +$3.45M 1.71% 20
2015
Q3
Sell
-14,150
Closed -$438K 90
2015
Q2
$438K Sell
14,150
-71,950
-84% -$2.12M 0.13% 88
2015
Q1
$2.87M Buy
+86,100
New +$2.91M 0.95% 39

Other funds holding PODD

Endurant Capital Management's PODD Position: Q1 2024 in Review

Endurant Capital Management sold out of Insulet (PODD) in Q1 2024, closing a stake of 3,906 shares — an estimated $848K sold.

Endurant Capital Management first reported a position in PODD in Q1 2015 and held it in 7 quarters. The position peaked at $3.23M in Q4 2018. 564 funds tracked by Wall St. Rank hold PODD as of Q1 2024.

  • Endurant Capital Management reported no remaining Insulet position as of Q1 2024 after selling out during the quarter.
  • Endurant Capital Management sold 3,906 Insulet shares in Q1 2024, an estimated $848K.
  • Endurant Capital Management first reported a position in Insulet in Q1 2015 and held it in 7 quarters.
  • Endurant Capital Management's Insulet position peaked at $3.23M in Q4 2018.
  • 564 funds tracked by Wall St. Rank held Insulet as of Q1 2024.

Based on Endurant Capital Management's 13F filing for Q1 2024.